DuPont Industrial Biosciences and ADM Announce Breakthrough

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DuPont Industrial Biosciences and ADM Announce Breakthrough Platform Technology for Long Sought-After Molecule

WILMINGTON, Del., Jan. 19, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Today, science and agricultural leaders DuPont Industrial Biosciences (DuPont) and Archer Daniels Midland Company (ADM) announced a new breakthrough process with the potential to expand the materials landscape in the 21st century with exciting and truly novel, high-performance renewable materials. The technology has applications in packaging, textiles, engineering plastics and many other industries.

The companies have developed a method for producing furan dicarboxylic methyl ester  (FDME) from fructose. FDME is a high-purity derivative of furandicarboxylic acid (FDCA), one of the 12 building blocks identified by the U.S. Department of Energy that can be converted into a number of high-value, bio-based chemicals or materials that can deliver high performance in a number of applications. It has long been sought-after and researched, but has not yet been available at commercial scale and at reasonable cost. The new FDME technology is a more efficient and simple process than traditional conversion approaches and results in higher yields, lower energy usage and lower capital expenditures.

This partnership brings together ADM's world-leading expertise in fructose production, and carbohydrate chemistry with DuPont's biotechnology, chemistry, materials and applications expertise, all backed by a strong joint intellectual-property portfolio.

"This molecule is a game-changing platform technology. It will enable cost-efficient production of a variety of 100 percent renewable, high-performance chemicals and polymers with applications across a broad range of industries," said Simon Herriott, global business director for biomaterials at DuPont. "ADM is an agribusiness powerhouse with strong technology development capabilities. They are the ideal partner with which to develop this new, renewable supply chain for FDME."

One of the first polymers under development utilizing FDME is polytrimethylene furandicarboxylate (PTF), a novel polyester also made from DuPont's proprietary Bio-PDO™ (1,3-propanediol). PTF is a 100-percent renewable and recyclable polymer that, when used to make bottles and other beverage packages, substantially improves gas-barrier properties compared to other polyesters. This makes PTF a great choice for customers in the beverage packaging industry looking to improve the shelf life of their products.

"We are excited about the potential FDME has to help our customers reach new markets and develop better-performing products, all made from sustainable, bio-based starting materials," said Kevin Moore, president, renewable chemicals at ADM. "With their strong leadership in the biomaterials industry, DuPont is a great partner that can help us bring this product to market for our customers."

ADM and DuPont are taking the initial step in the process of bringing FDME to market by moving forward on the scale-up phase of the project. The two companies are planning to build an integrated 60 ton-per-year demonstration plant in Decatur, Ill., which will provide potential customers with sufficient product quantities for testing and research.

For more information about this project, please visit: click here .

For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM ) have transformed crops into products that serve the vital needs of a growing world. Today, we're one of the world's largest agricultural processors and food ingredient providers, with more than 33,000 employees serving customers in more than 140 countries. With a global value chain that includes more than 460 crop procurement locations, 300 ingredient manufacturing facilities, 40 innovation centers and the world's premier crop transportation network, we connect the harvest to the home, making products for food, animal feed, industrial and energy uses. Learn more at http://www.adm.com .

DuPont Industrial Biosciences works with customers across a wide range of industries to improve products and make processes more sustainable. Through a unique combination of biotechnology, chemical and material science capabilities, we're focused on providing market-driven, biobased solutions to meet the needs of a growing population, while protecting our environment for future generations.

DuPont (NYSE: DD ) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit dupont.com .

Forward-Looking Statements: This document contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

# # #

01/19/16

The DuPont Oval logo, DuPont™ and all products, unless otherwise noted, denoted with ™, ℠or ® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/dupont-industri...171148.htm

DuPont Wendy Rosen 650-284-6429

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 688

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 531

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 220

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 382

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Nutex Health Inc: Understanding Recent Legal Developments

Updated Category News Views 119

Overview of Nutex Health Inc. Nutex Health Inc. (NASDAQ: NUTX) is a key player in the healthcare sector, known for its innovative services and strategies aimed at enhancing patient care. As investors, it is crucial to stay informed about potential impacts to the company’s stock due to various legal challenges. Recent Legal Actions Recently, the law firm Kirby McInerney...

Continue Reading
Cyber Threats: 65% of Firms Fear Survival Risks

Updated Category News Views 18

A Wake-Up Call for Businesses If you thought the cyber threats were just a sideshow, think again. Sixty-five percent of businesses are tossing around the notion that a serious cyber attack could knock them out for good. Databarracks just unveiled its 2026 Data Health Check, airing out the gloomy stats we frankly can't ignore anymore. Cyber Attacks: More Than Just a...

Continue Reading
Understanding the Recent Supplementary Prospectus Release

Updated Category News Views 122

Overview of the Supplementary Prospectus Hargreave Hale AIM VCT plc has recently released a supplementary prospectus approved by the Financial Conduct Authority. This document is essential for investors seeking to understand recent developments regarding the company's financial situation. Purpose of the Supplementary Prospectus The supplementary prospectus is a regulatory...

Continue Reading
Carbliss Celebrates Launch in Arizona After Record Growth

Updated Category News Views 170

Carbliss Launches in Arizona: A Significant Expansion Carbliss has officially launched in Arizona, enhancing its reach and marking a pivotal point in the brand's journey. This premium ready-to-drink cocktail brand, known for its zero sugar, zero carb, and 100 calorie beverages, has made a notable impact in the beverage industry through a focus on quality and consumer...

Continue Reading
MicroStrategy's Bold Investment in Bitcoin Sparks Debate

Updated Category News Views 85

MicroStrategy's Bold Investment Strategies As the world watches Bitcoin prices soar to new heights, MicroStrategy's aggressive accumulation of Bitcoin has become a hot topic in the crypto community. Many traders and analysts are scrutinizing the company's strategy as it continues to amass significant Bitcoin holdings. Understanding Recent Developments Industry expert Alex...

Continue Reading